Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gabapentin withdrawal syndrome.

J W Norton1

  • 1Department of Medical Psychiatry, University of Mississippi School of Medicine, Jackson, Mississippi 39212, USA.

Clinical Neuropharmacology
|August 2, 2001
PubMed
Summary
This summary is machine-generated.

Abruptly stopping gabapentin (GBP) can cause withdrawal symptoms. Healthcare providers should advise patients to taper GBP dosage gradually to avoid these adverse effects.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gabapentin-related dyskinesia.

Journal of clinical psychopharmacology·2002
Same author

Foreign accent-like syndrome during psychotic exacerbations.

Neuropsychiatry, neuropsychology, and behavioral neurology·2001
Same author

The use of intravenous valproate in acute mania.

General hospital psychiatry·2001
Same author

Personality disorders in the primary care setting.

The Nurse practitioner·2001
Same author

Acute dystonia with quetiapine.

Clinical neuropharmacology·2000
Same author

Is academic medicine for sale?

The New England journal of medicine·2000
Same journal

Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.

Clinical neuropharmacology·2026
Same journal

Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.

Clinical neuropharmacology·2026
Same journal

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

Clinical neuropharmacology·2026
Same journal

A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.

Clinical neuropharmacology·2026
Same journal

Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.

Clinical neuropharmacology·2026
Same journal

Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.

Clinical neuropharmacology·2026
See all related articles

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Gabapentin (GBP) is widely prescribed for epilepsy, pain, migraine, and bipolar disorder.
  • GBP is known for its favorable side effect profile, minimal drug interactions, lack of hepatic metabolism, and renal excretion.

Observation:

  • Three patient cases illustrate withdrawal symptoms following abrupt gabapentin discontinuation.
  • These symptoms occurred despite GBP's generally benign side effect profile.

Findings:

  • Abrupt cessation of gabapentin can precipitate withdrawal syndromes.
  • The risk may be higher in patients on high-dose therapy.

Implications:

  • Clinicians should recommend a gradual dose tapering schedule for gabapentin discontinuation.
  • Educating patients on potential adverse effects of abrupt GBP cessation is crucial for safe management.